Cargando…

Metformin Downregulates the Expression of Epidermal Growth Factor Receptor Independent of Lowering Blood Glucose in Oral Squamous Cell Carcinoma

PURPOSE: Type 2 diabetes mellitus (T2DM) is among the risk factors for the occurrence and development of cancer. Metformin is a potential anticancer drug. Epidermal growth factor receptor (EGFR) plays an important role in the progression of oral squamous cell carcinoma(OSCC), but the relationship be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wei-Ming, Yang, Si-Si, Shao, Shu-Hui, Nie, Huan-Quan, Zhang, Jing, Su, Tong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864766/ https://www.ncbi.nlm.nih.gov/pubmed/35222283 http://dx.doi.org/10.3389/fendo.2022.828608

Ejemplares similares

Life Under Hypoxia Lowers Blood Glucose Independently of Effects on Appetite and Body Weight in Mice
por: Abu Eid, Sameer, et al.
Publicado: (2018)

Heat Shock Proteins 70 Regulate Cell Motility and Invadopodia-Associated Proteins Expression in Oral Squamous Cell Carcinoma
por: Ding, Le-Xi, et al.
Publicado: (2022)

Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites
por: Wang, Dongmei, et al.
Publicado: (2022)

Induction of remission in diabetes by lowering blood glucose
por: Weir, Gordon C., et al.
Publicado: (2023)

Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
por: Yang, Zhi-Min, et al.
Publicado: (2022)

Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme
por: Khunti, Kamlesh, et al.
Publicado: (2020)

Jinlida granules combined with metformin improved the standard-reaching rate of blood glucose and clinical symptoms of patients with type 2 diabetes: secondary analysis of a randomized controlled trial
por: Kang, Xiaomin, et al.
Publicado: (2023)

Prediction of Glucose Tolerance without an Oral Glucose Tolerance Test
por: Babbar, Rohit, et al.
Publicado: (2018)

Remnant cholesterol is independently asssociated with an increased risk of peripheral artery disease in type 2 diabetic patients
por: Song, Yi, et al.
Publicado: (2023)

Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes
por: Meng, Ziyu, et al.
Publicado: (2023)

Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area: A Retrospective Cohort Study
por: Vlacho, Bogdan, et al.
Publicado: (2021)

Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
por: Horakova, Olga, et al.
Publicado: (2019)

Childhood Maltreatment Is an Independent Risk Factor for Prediabetic Disturbances in Glucose Regulation
por: Li, Li, et al.
Publicado: (2017)

Metformin: Focus on Melanoma
por: Jaune, Emilie, et al.
Publicado: (2018)

Metformin in Reproductive Biology
por: Faure, Melanie, et al.
Publicado: (2018)

Metformin and Colorectal Cancer
por: Higurashi, Takuma, et al.
Publicado: (2018)

The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection
por: Brown, Emily, et al.
Publicado: (2021)

Editorial: Metformin: Beyond Diabetes
por: Bost, Frédéric, et al.
Publicado: (2019)

Comparison of Clinical Efficacy and Safety of Metformin Sustained-Release Tablet (II) (Dulening) and Metformin Tablet (Glucophage) in Treatment of Type 2 Diabetes Mellitus
por: Guo, Li-xin, et al.
Publicado: (2021)

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023)

Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass
por: Laferrère, Blandine, et al.
Publicado: (2018)

Impact of Incretin Hormone Receptors on Insulin-Independent Glucose Disposal in Model Experiments in Mice
por: Ovlund, Tina, et al.
Publicado: (2021)

Nocturnal melatonin increases glucose uptake via insulin-independent action in the goldfish brain
por: Watanabe, Kazuki, et al.
Publicado: (2023)

Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages
por: Lin, Yi-Hsuan, et al.
Publicado: (2019)

The Therapeutic Potential of Metformin in Neurodegenerative Diseases
por: Rotermund, Carola, et al.
Publicado: (2018)

Role of Mitochondria in the Mechanism(s) of Action of Metformin
por: Vial, Guillaume, et al.
Publicado: (2019)

Metformin and Its Benefits for Various Diseases
por: Lv, Ziquan, et al.
Publicado: (2020)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

Fluvastatin Reduces Glucose Tolerance in Healthy Young Individuals Independently of Cold Induced BAT Activity
por: Felder, Martina, et al.
Publicado: (2021)

The Presence of Serum TgAb Suggests Lower Risks for Glucose and Lipid Metabolic Disorders in Euthyroid General Population From a National Survey
por: Zhang, Jinjia, et al.
Publicado: (2020)

Stratified glucose-lowering response to vildagliptin and pioglitazone by obesity and hypertriglyceridemia in a randomized crossover trial
por: Brandon, Rebecca, et al.
Publicado: (2023)

Acarbose With Comparable Glucose-Lowering but Superior Weight-Loss Efficacy to Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Fang, et al.
Publicado: (2020)

Metformin, an Anti-diabetic Drug to Target Leukemia
por: Biondani, Giulia, et al.
Publicado: (2018)

Metabolic Profiles Associated With Metformin Efficacy in Cancer
por: Andrzejewski, Sylvia, et al.
Publicado: (2018)

The Potential Effect of Metformin on Cancer: An Umbrella Review
por: Yu, Hong, et al.
Publicado: (2019)

Hypothesis: Metformin is a potential reproductive toxicant
por: Tavlo, Maja, et al.
Publicado: (2022)

Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study
por: Mor, Anil, et al.
Publicado: (2016)

Polysaccharide IV from Lycium barbarum L. Improves Lipid Profiles of Gestational Diabetes Mellitus of Pregnancy by Upregulating ABCA1 and Downregulating Sterol Regulatory Element-Binding Transcription 1 via miR-33
por: Yang, Shuli, et al.
Publicado: (2018)

Metformin treatment and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in Beijing, China
por: Yang, Ruotong, et al.
Publicado: (2023)

Blood glucose may be another index to initiate insulin treatment besides glycated hemoglobin A1c after oral antidiabetic medications failure for glycemic control: A real–world survey
por: Li, Yanli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2s07pfr5vf3tol4ddihmfta348